Purogiramu inonzi Afatinib Dimaleate CAS 850140-73-7 Purity >99.5% (HPLC)
Ruifu Chemical Supply Intermediates yeAfatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-imwe CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineCAS 314771-88-5
Chemical Name | Afatinib Dimaleate |
Mashoko anoreva zvakafanana | BIBW2992 Dimaleate;(S,E)-N-(4-(3-Chloro-4-Fluorophenylamino)-7-(Tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)asi-2-Enamide Dimaleate |
Nhamba yeCAS | 618-89-3 |
Nhamba yeCAT | RF-PI2032 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C32H33ClFN5O11 |
Molecular Weight | 718.08 |
Sensitivity | Hunyoro Inonzwa |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kusvika kuOff-White Powder |
Kuchena / Analysis Method | >99.5% (HPLC) |
Kurasika paKuomesa | <0.50% |
Residue paIgnition | <0.10% |
Maximum Single Kusachena | <0.30% |
Zvose Zvisina Kuchena | <0.50% |
Heavy Metals (as Pb) | ≤20ppm |
Infrared Spectrum | Inopindirana neChimiro |
NMR | Inopindirana neChimiro |
Test Standard | Enterprise Standard |
Sherufu Hupenyu | Mwedzi 24 Kana Yakachengetwa Zvakanaka |
Usage | API |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
Afatinib Dimaleate (CAS: 850140-73-7), iyo dimaleate munyu fomu yeafanitib, inowanikwa nemuromo antineoplastic agent.Afatinib Dimaleate is irreversible EGFR family inhibitor ine IC50s ye0.5 nM, 0.4 nM, 10 nM uye 14 nM yeEGFRwt, EGFRL858R, EGFRL858R/T790M uye HER2, zvichiteerana.Afatinib Dimaleate inoratidzwa kune yekutanga-mutsara kurapwa kwevarwere vane metastatic isiri-diki cell kenza yemapapu (NSCLC) vane mapundu ane epidermal growth factor receptor (EGFR) exon 19 deletions kana exon 21 (L858R) inotsiva shanduko sezvaonekwa neFDA- bvunzo dzakabvumidzwa.Kare, kurapwa kwakajairwa neplatinum-based chemotherapy doublet regimen yaionekwa seyakajairwa mutsara wekutanga kurapwa kune vese varwere vane NSCLC.Nekudaro, humbowo huri kubuda hwakaratidza madiki umo kurapa kwakanangwa kunoshanda zvakanyanya, zvichitungamira mukugadzirwa kwemishonga-yakanangana nekuchinja.Afatinib Dimaleate Yakagadzirwa naBoehringer Ingelheim Pharmaceuticals, Afatinib Dimaleate yakabvumidzwa neFDA muna 2013 semushonga wenherera pasi pezita rekutengesa Gilotrif.Afatinib Dimaleate inogadzirwa nemakemikari uchishandisa yakajairwa nzira.Afatinib Dimaleatehaisi kungoshanda chete kupesana neEGFR kuchinja kunotarirwa nechizvarwa chekutanga TKIs se erlotinib kana gefitinib, asiwo kurwisana nekuchinja kwakafanana neT790M iyo isinganzwisisi kune aya maitiro ekurapa.Nekuda kwebasa rayo rekuwedzera kurwisa Her2, iri kuongororwa gomarara rezamu pamwe nemamwe EGFR uye Her2 inofambiswa negomarara.